Back

Thrombolysis versus primary percutaneous coronary intervention in patients with suspected ST-elevation myocardial infarction - a SWEDEHEART observational study

31 August 2024 (07:55 - 08:50)
Organised by: Logo
Congress Presentation Part of: Risk stratification in percutaneous coronary intervention (1) Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Benjamin Isma

Lund (Sweden)

8 More presentations in this session

Presentation thumbnail
A new hydration strategy can reduce contrast-induced acute kidney injury after PCI in patients with chronic heart failure and chronic kidney disease: a two-center randomized controlled trial
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Prognostic outcome of ACS in HTX patients after PCI
Ms L. Elbinger (Bad Oeynhausen, DE)
Abstract Slides Video
Presentation thumbnail
The use of allopurinol in prophylaxis against contrast-induced nephropathy in patients undergoing percutaneous coronary intervention
Doctor K. Mahmoud (Cairo, EG)
Abstract Slides Video
Presentation thumbnail
Clinical impact of systemic inflammation across the spectrum of different high-sensitivity CRP values in patients undergoing percutaneous coronary intervention
Doctor A. Oliva (New York, US)
Abstract Slides Video
Presentation thumbnail
Gender differences in coronary artery disease patterns
Doctor D. Munhoz (Aalst, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in percutaneous coronary intervention (1)

The Event

Event poster

ESC Congress 2024

31 August 2024 07:55 CET
You may be interested in
thumbnail
Congress Presentation
5-year mortality after ST-segment elevation myocardial infarction compared to the general population
29 August 2025
thumbnail
Congress Presentation
Fibrinolysis in rural areas.
19 March 2022
thumbnail
Congress Presentation
Is spontaneous pre-hospital coronary reperfusion in STEMI safe ?
1 September 2025
thumbnail
Congress Presentation
Impact of trial results and guidelines on the practice of Primary PCI over 14 years
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources